Rekombinanter TNFRSF18 (Ragifilimab Biosimilar) Antikörper
Research Grade
Reaktivität: Human
Wirt: Humanized
Chimeric
unconjugated
Recombinant Antibody
-
- Target Alle TNFRSF18 (Ragifilimab Biosimilar) Produkte
- TNFRSF18 (Ragifilimab Biosimilar)
- Antikörpertyp
- Recombinant Antibody
- Reaktivität
- Human
-
Wirt
-
Humanized
- Expressionssystem
- Mammalian cells
-
Klonalität
- Chimeric
-
Konjugat
- Dieser TNFRSF18 (Ragifilimab Biosimilar) Antikörper ist unkonjugiert
- Applikation
- Bitte anfragen
- Verwendungszweck
- Research Grade Ragifilimab Biosimilar Antibody
- Spezifität
- Activation-inducible TNFR family receptor, GITR, TNFRSF18, CD357, Tumor necrosis factor receptor superfamily member 18, AITR, Glucocorticoid-induced TNFR-related protein
- Aufreinigung
- Protein A or G purified from cell culture supernatant.
- Reinheit
- >95 % by SDS-PAGE.
- Güteklasse
- Research Grade
- Isotyp
- IgG1 kappa
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 2 mg/mL
- Buffer
- 0.01M PBS, pH 7.4.
- Lagerung
- 4 °C,-20 °C,-80 °C
- Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
- Haltbarkeit
- 12 months
-
- Target
- TNFRSF18 (Ragifilimab Biosimilar)
- Andere Bezeichnung
- Ragifilimab Biosimilar (TNFRSF18 (Ragifilimab Biosimilar) Produkte)
- Substanzklasse
- Biosimilar
- Hintergrund
- Activation-inducible TNFR family receptor, GITR, TNFRSF18, CD357, Tumor necrosis factor receptor superfamily member 18, AITR, Glucocorticoid-induced TNFR-related protein
- UniProt
- Q9Y5U5
-
Sie sind hier:
